SIGA Technologies, Inc. (SIGA) Stock Score, Valuation & Financial Research
SIGA Technologies, Inc. is in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 45/100.
Quick answer for SIGA
SIGA Technologies, Inc. currently has a Wall Street Score of 45/100. The stored market price is $3.03. Its financial score is 46/100. Its valuation score is 29/100. These figures are a research snapshot, not a buy or sell recommendation.
What SIGA Technologies, Inc. does
SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.
SIGA financial snapshot
- Wall Street Score:
- 45/100
- Current price:
- $3.03
- Market capitalization:
- $217.3M
- Revenue:
- $93.8M
- Net income:
- $20.3M
- Free cash flow:
- $43.1M
- Cash:
- $145.6M
- Total debt:
- $638K
- EPS:
- 0.33
- P/E ratio:
- 9.2x
- Financial score:
- 46/100
- Valuation score:
- 29/100
- Revenue score:
- 22/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $43.1M, showing positive cash generation.
- The balance sheet shows $145.6M of cash versus $638K of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 29/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 46/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research SIGA
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.